Trial intelligence / Profile preview

Comparison of efficacy of extended release venlafaxine versus sertraline in treatment of patients with major depressive disorder

IRCT2017011631626N3Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in major depressive disorder (MDD) comparing Venlafaxine extended release with Sertraline (2 arms). Started Feb 2017; status: completed.

02

Drugs

venlafaxinesertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT2017011631626N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017011631626N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call